Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Salt Formation Technology. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel solvent system for Sodium Rabeprazole ensures high stability and low moisture, offering cost reduction in pharmaceutical intermediate manufacturing.
Stable chiral intermediate synthesis via CN109851542A. Enhanced storage stability and cost reduction in pharmaceutical intermediate manufacturing for global supply chains.
Patent CN1215045C discloses high-purity crystalline salts of 3,3-diphenylpropylamine derivatives, offering superior stability and bioavailability for urinary incontinence treatments.
Novel mesylate salt formation improves purity and yield. Reduces dimer impurities. Ideal for scalable pharma manufacturing.
Patent CN108101881B details a novel salt formation process for trabectedin intermediates, replacing difficult chromatography with crystallization for superior purity and supply chain stability.
Patent CN114591273A reveals a solid-state synthesis route for high-purity Alfuzosin intermediates, offering superior stability and cost reduction in pharmaceutical manufacturing.
Novel crystalline cephamycin intermediate via salt formation. Enhances stability and purity for cefminox sodium production. Reliable supply chain solution.